A priori activation of apoptosis pathways of tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment

Authors

Raghu S. Pandurangi, Sci-Engi-Medco Solutions Inc., St Charles, Missouri
Marco Tomasetti, Polytechnic University of Marche, Ancona
Sekar T. Verapazham, Stanford University
Ramasamy Paulmurugan, Stanford University
Cynthia Ma, Washington University School of Medicine in St. Louis
Sandeep Rajput, Washington University School of Medicine in St. Louis
Manjushree Anjanappa, Indiana University, Indianapolis
Harikrishna Nakshatri, Indiana University, Indianapolis

Journal

PLoS One

Publication Date

1-1-2021

Volume

16

Issue

2

First Page

e0225869

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0225869

Rights and Permissions

Pandurangi RS, Tomasetti M, Verapazham ST, Paulmurugan R, Ma C, et al. (2021) A priori activation of apoptosis pathways of tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment. PLOS ONE 16(2): e0225869. https://doi.org/10.1371/journal.pone.0225869

Recommended Citation

Pandurangi, Raghu S.; Tomasetti, Marco; Verapazham, Sekar T.; Paulmurugan, Ramasamy; Ma, Cynthia; Rajput, Sandeep; Anjanappa, Manjushree; and Nakshatri, Harikrishna, "A priori activation of apoptosis pathways of tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment." PLoS One. 16, 2. e0225869 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10162